156 related articles for article (PubMed ID: 7390046)
1. Effects of chenodeoxy- and ursodeoxycholic acid on absorption, secretion and permeability in rat colon and small intestine.
Caspary WF; Meyne K
Digestion; 1980; 20(3):168-74. PubMed ID: 7390046
[TBL] [Abstract][Full Text] [Related]
2. [Effects of chenodeoxycholic acid (CDCA) and ursodeoxycholic (UDCA) to glucose transport in hamster small intestine in vitro--a study on the mechanism of diarrhea due to CDCA therapy (author's transl)].
Nakamura T; Ohkuni A; Yamanaka M
Nihon Shokakibyo Gakkai Zasshi; 1980 Sep; 77(9):1355-61. PubMed ID: 7441911
[No Abstract] [Full Text] [Related]
3. The cholecystokinin effect on human intestinal permeability: influence of chenodeoxycholic and ursodeoxycholic acid administration.
Budillon G; Parrilli G; Capuano G; Mazzacca G; Menzies IS
Digestion; 1982; 24(4):274-80. PubMed ID: 7152150
[TBL] [Abstract][Full Text] [Related]
4. Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids.
Stiehl A; Raedsch R; Rudolph G
Gastroenterology; 1990 Feb; 98(2):424-8. PubMed ID: 2295398
[TBL] [Abstract][Full Text] [Related]
5. Chenodeoxycholic and ursodeoxycholic acids alter motility and fluid transit in the canine ileum.
Kruis W; Haddad A; Phillips SF
Digestion; 1986; 34(3):185-95. PubMed ID: 3758514
[TBL] [Abstract][Full Text] [Related]
6. [The influence of chenodeoxycholic acid and ursodeoxycholic acid on the hepatic structure of the rat (author's transl)].
Leuschner U; Schneider M; Korte L
Z Gastroenterol; 1979 Apr; 17(4):244-55. PubMed ID: 433375
[TBL] [Abstract][Full Text] [Related]
7. Effect of sodium chenodeoxycholate on oxalate absorption from the excluded human colon--a mechanism for 'enteric' hyperoxaluria.
Fairclough PD; Feest TG; Chadwick VS; Clark ML
Gut; 1977 Mar; 18(3):240-4. PubMed ID: 852753
[TBL] [Abstract][Full Text] [Related]
8. UDCA and CDCA alleviate 17α-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats.
Li X; Yuan Z; Liu R; Hassan HM; Yang H; Sun R; Zhang L; Jiang Z
Toxicol Appl Pharmacol; 2016 Nov; 311():12-25. PubMed ID: 27743861
[TBL] [Abstract][Full Text] [Related]
9. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
Hillaire S; Ballet F; Franco D; Setchell KD; Poupon R
Hepatology; 1995 Jul; 22(1):82-7. PubMed ID: 7601437
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of ursodeoxycholic acid on N-methylnitrosourea-induced colon carcinogenesis and colonic mucosal telomerase activity in F344 rats.
Narisawa T; Fukaura Y; Terada K; Sekiguchi H
J Exp Clin Cancer Res; 1999 Jun; 18(2):259-66. PubMed ID: 10464717
[TBL] [Abstract][Full Text] [Related]
11. Different effects of chenodeoxycholic acid and ursodeoxycholic acid on serum lipoprotein concentrations in patients with radiolucent gallstones.
Leiss O; von Bergmann K
Scand J Gastroenterol; 1982 Aug; 17(5):587-92. PubMed ID: 7178821
[TBL] [Abstract][Full Text] [Related]
12. Effects of fatty acid esters of cheno- and ursodeoxycholic acids on gallstone formation in hamsters.
Kritchevsky D; Klurfeld DM; Sirtori C
Pharmacol Res Commun; 1986 Nov; 18(11):997-1002. PubMed ID: 3797448
[TBL] [Abstract][Full Text] [Related]
13. Feeding rats diets containing cheno- or ursodeoxycholic acid or cholestyramine modifies intestinal uptake of glucose and lipids.
Thomson AB; Keelan M
Digestion; 1987; 38(3):160-70. PubMed ID: 3443226
[TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid and cholesterol induce enterohepatic cycling of bilirubin in rodents.
Méndez-Sánchez N; Brink MA; Paigen B; Carey MC
Gastroenterology; 1998 Sep; 115(3):722-32. PubMed ID: 9721170
[TBL] [Abstract][Full Text] [Related]
15. Physical-chemical properties of chenodeoxycholic acid and ursodeoxycholic acid.
Hisadome T; Nakama T; Itoh H; Furusawa T
Gastroenterol Jpn; 1980; 15(3):257-63. PubMed ID: 7399224
[TBL] [Abstract][Full Text] [Related]
16. Liquid crystal formation in ursodeoxycholate-rich human gallbladder bile.
Igimi H; Asakawa S; Watanabe D; Shimura H
Gastroenterol Jpn; 1983 Apr; 18(2):93-7. PubMed ID: 6852442
[TBL] [Abstract][Full Text] [Related]
17. [Dissolution of biliary calculi with CDCA and UDCA].
Sugata F
Nihon Rinsho; 1984 Jul; 42(7):1683-9. PubMed ID: 6387220
[No Abstract] [Full Text] [Related]
18. Displacing effects of chenodeoxycholic acid, ursodeoxycholic acid and sulfadimethoxine on plasma protein binding of tolbutamide.
Goto S; Watanabe S; Maehara S; Nakata Y; Tateyama T
J Pharmacobiodyn; 1985 Jun; 8(6):440-7. PubMed ID: 4057039
[TBL] [Abstract][Full Text] [Related]
19. In vitro transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal flora, with particular reference to the mutual conversion between the two bile acids.
Hirano S; Masuda N; Oda H
J Lipid Res; 1981 Jul; 22(5):735-43. PubMed ID: 7288282
[TBL] [Abstract][Full Text] [Related]
20. Suppression of renal disease and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid.
Suwannaroj S; Lagoo A; McMurray RW
Lupus; 2001; 10(8):562-7. PubMed ID: 11530998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
